The envelope glycoprotein of HIV‐1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV‐1, and share antigenic homology
- 1 February 1994
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (2) , 294-300
- https://doi.org/10.1002/eji.1830240203
Abstract
Gp41, the transmembrane glycoprotein of HIV-1, has been shown to be non-covalently associated with gp120. We have shown that it also binds human C1q. To analyze the interaction site(s) of gp41 with these two molecules, we established an enzyme-linked immunosorbent assay (ELISA) system using recombinant soluble gp41 [amino acids (aa) 539–684] and peptides thereof. In the cell-external part of gp41 three sites (aa 526–538, aa 590–613 and aa 625–655) were found to bind both gp120 and C1q. That gp120 and C1q use the same sites was evidenced by the fact that these proteins competed with each other for the same sites in recombinant soluble gp41 and gp41 peptides. It could be demonstrated by ELISA, that rabbit antibodies against human C1q recognized gp120, and rabbit antibodies against gp120 cross-reacted with C1q. Rabbit anti-gp120, HIV-1-positive human sera and anti-gp120 obtained from such sera agglutinated sensitized sheep erythrocytes with human C1q (EAC1q). These data suggest that in addition to functional homology between C1q and gp120 structural homology between these two molecules exists. This molecular mimicry might become the basis for immunologically relevant autoimmune phenomena.Keywords
This publication has 49 references indexed in Scilit:
- HIV and human complement: mechanisms of interaction and biological implicationImmunology Today, 1993
- HIV-I and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cellsAIDS, 1993
- Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.The Journal of Experimental Medicine, 1991
- Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formationAIDS, 1991
- HIV and HIV-infected cells differentially activate the human complement system independent of antibodyImmunology Letters, 1989
- Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.Journal of Clinical Investigation, 1988
- Enzymatic alteration of C1q, the collagen‐like subcomponent of the first component of complement, leads to cross‐reactivity with type II collagenFEBS Letters, 1988
- Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virusCell, 1987
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Differential elution of Clq, Cl̄r and Cl̄s from human CT bound to immune aggregates. use in the rapid purification of Cl̄ sub-componentsMolecular Immunology, 1979